Media

Our latest news, announcements and multimedia resources

Latest news

September 29, 2022

U.S. Court of Appeals for the Federal Circuit Rules in Favor of Merck in Sitagliptin Dihydrogen Phosphate Patent Lawsuit

September 29, 2022

Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27

September 27, 2022

Merck Animal Health Completes Minority Investment in LeeO Precision Farming

September 27, 2022

Merck’s KEYTRUDA® (pembrolizumab) Receives Four New Approvals in Japan, Including in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC)

September 22, 2022

Merck Animal Health to Acquire Vence

September 22, 2022

LYNPARZA® (olaparib) Approved in China as First-Line Maintenance Treatment With Bevacizumab for Homologous Recombination Deficient (HRD)-Positive Advanced Ovarian Cancer

LYNK-003 Trial Evaluating LYNPARZA® (olaparib) With or Without Bevacizumab in Patients With Unresectable or Metastatic Colorectal Cancer to Stop for Futility

Merck Announces Commitments to Pandemic Response as Part of 2nd Global COVID-19 Summit

Merck to continue supplying essential medicines and vaccines in Russia and will donate any profit from Russia to humanitarian causes

February 19, 2022

Merck and Ridgeback Statement on Clinical Trial of Hetero’s Generic Molnupiravir

November 23, 2021

Gilead and Merck Announce Temporary Pause in Enrollment for Phase 2 Study Evaluating an Oral Weekly Combination Regimen of Investigational Islatravir and Investigational Lenacapavir

September 23, 2021

Merck Announces Settlement and License Agreement Resolving Pneumococcal Conjugate Vaccine Patent Litigation

Media resources

News releases

Read our latest news releases.

Company statements

Read our latest company statements.

Media library

Access videos, logos, photos and infographics.

Media contact details

General
General media inquiries

+1 908-740-5633

mediarelations@merck.com

Melissa Moody
Corporate and scientific media relations

melissa.moody@merck.com

Get to know us through our stories

Everything we do, in and out of the laboratory, is based on our deep appreciation for life. Get a glimpse of what it’s like on the inside through our stories.

Scientist reviewing test tubes

We are driven by a single purpose

We use the power of leading-edge science to save and improve lives around the world.

Learn more about our company

Person reviewing product pipeline on their smartphone

Investor relations

Find our latest financials, events & presentations, news, stock information and investor contacts.

Visit investor relations

Two employees in the lobby on their laptops

Company fact sheet

Access company information including stock ticker, official company names, description, and more.

See company fact sheet

Unsubscribe from email alerts